MAFLD (metabolic associated fatty liver disease) outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct antiviral agents

Journal of Hepatology(2023)

引用 1|浏览19
暂无评分
关键词
fatty liver disease,ultrasonographic steatosis,hepatocellular carcinoma,hepatocellular carcinoma risk
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要